drug
ONDANSETRON
Preclinicalupdated 5mo agoby $ASBP Aspire Biopharma Holdings, Inc.
Preclinicalcommunity read0 votes
🐶 often sniffed alongside
top 8- tagApproval382 co-mentions · 163 sources
- drugondansetron ODT250 co-mentions · 166 sources
- drugondansetron hydrochloride ODT250 co-mentions · 166 sources
- drugONDANSETRON HYDROCHLORIDE208 co-mentions · 124 sources
- drugondansetron hydrochloride CR208 co-mentions · 124 sources
- drugONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE208 co-mentions · 124 sources
- tagSmall Molecule92 co-mentions · 92 sources
- companyAurobindo Pharma Ltd29 co-mentions · 29 sources
all catalysts(0)
nothing on the calendar yet
Trials studying ONDANSETRON
- phase2Study With IV NEPA (Fosnetupitant/Palonosetron) for the Prevention of Chemotherapy-induced Nausea and Vomiting in Paediatric Cancer Patients Undergoing Highly Emetogenic Chemotherapy (HEC)
- —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- phase1Phase I PK and Safety Study of Ondansetron Inhalation Powder
- phase3A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
- phase1A Trial to Evaluate Interactions Between Antiemetic Medication and AMG 133 in Participants Living With Overweight or Obesity
- phase4Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk)
- phase1Buprenorphine-Fentanyl Interaction Study
- phase2A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that